STOCK TITAN

Sonendo, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Sonendo, Inc. (SONX) will report financial results for Q4 and full year 2023 on March 11th, 2024. A conference call will be held to discuss the results. Investors can listen via phone or webcast.
Positive
  • None.
Negative
  • None.

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Sonendo, Inc. (“Sonendo”) (OTCQX: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the fourth quarter and full year 2023 after the market close on Monday, March 11th, 2024. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results.

Investors interested in listening to the conference call may do so by dialing (833) 470-1428 for domestic callers or (404) 975-4839 for international callers, using access code: 426330. Live audio of the webcast will be available at: https://investor.sonendo.com.

An archived recording will be available on the “Investors” section of the company’s website at: https://investor.sonendo.com. The webcasts will be available for replay for at least 90 days after the event.

About Sonendo

Sonendo is a commercial-stage medical technology company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo develops and manufactures the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. The clinical benefits of the GentleWave System when compared to conventional methods of root canal therapy include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing and minimal to no post-operative pain. In addition, the GentleWave System can improve the workflow and economics of dental practices. Sonendo is also the parent company of TDO® Software, the developer of widely used endodontic practice management software solutions, designed to simplify practice workflow. TDO Software integrates practice management, imaging, referral reporting and CBCT imaging, and offers built-in communication with the GentleWave System.

For more information on Sonendo, visit www.sonendo.com. For more information on the GentleWave System, visit www.gentlewave.com/doctor.

Investor Contact

Gilmartin Group

Greg Chodaczek

ir@sonendo.com

Source: Sonendo

Sonendo will report financial results for Q4 and full year 2023 on March 11th, 2024.

Investors can listen to the conference call by dialing (833) 470-1428 for domestic callers or (404) 975-4839 for international callers, using access code: 426330. Live audio of the webcast will be available at: https://investor.sonendo.com.

An archived recording will be available on the 'Investors' section of the company’s website at: https://investor.sonendo.com. The webcasts will be available for replay for at least 90 days after the event.
Sonendo Inc

OTC:SONX

SONX Rankings

SONX Latest News

SONX Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link

About SONX

sonendo®, inc. is a privately held, venture-backed company developing innovative technologies to save teeth through sound science®. sonendo’s multisonic ultracleaning™ technology is elevating the level of clean throughout endodontics and dentistry. by introducing broad spectrum acoustic technology, sonendo is helping to reduce doctors’ reliance on standard instrumentation while saving teeth¹ and changing patients’ lives. after years of research and development, sonendo’s gentlewave® system presents an entirely new way of thinking about root canal therapy. using closed-loop, multisonic ultracleaning technology, the gentlewave system reaches deep into the lateral canals and microscopic tubules of the root canal system to remove tissue, debris, biofilm and bacteria.² ³ your practice can offer unprecedented cleaning with the gentlewave system. sonendo investors include cvf, llc, dinova capital, fjord ventures, meritech capital partners, neomed management, orbimed advisors llc, seb private